KASL Clinical Practice Guidelines: Management of chronic hepatitis B

2012 Clinical and Molecular Hepatology 18, 2 (109-162)

Although the efficacy of noninvasive methods such as using the Fibroscan device or measuring potential serum markers in assessing fibrosis in CHB has been studied in the past few years, such methods are not yet recommended as a diagnostic or decision-making tool for treatment...

Pubmed : PMC3415874